Published in Am J Psychiatry on June 01, 2004
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology (2013) 1.51
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One (2013) 1.36
Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol (2009) 1.26
The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol (2010) 1.05
Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry (2013) 0.95
A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord (2011) 0.92
A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders. J Neural Transm (Vienna) (2007) 0.83
[Multidimensional pain assessment in patients with dementia]. Schmerz (2007) 0.80
Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis. J Alzheimers Dis (2015) 0.79
Rates of depression in individuals with pathologic but not clinical Alzheimer disease are lower than those in individuals without the disease: findings from the Baltimore Longitudinal Study on Aging (BLSA). Alzheimer Dis Assoc Disord (2007) 0.78
Serotonin 6 receptor controls alzheimer's disease and depression. Oncotarget (2015) 0.78
Factors associated with a depressive disorder in Alzheimer's disease are different from those found for other dementia disorders. Dement Geriatr Cogn Dis Extra (2012) 0.78
Late-life depression is not associated with dementia-related pathology. Neuropsychology (2016) 0.76
Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model. Cardiovasc Psychiatry Neurol (2010) 0.76
Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment. PLoS One (2016) 0.75
Organic bases of late-life depression: a critical update. J Neural Transm (Vienna) (2013) 0.75
Chronic administration of 13-cis-retinoic acid does not alter the number of serotoninergic neurons in the mouse raphe nuclei. Neuroscience (2010) 0.75
Vascular depression consensus report - a critical update. BMC Med (2016) 0.75
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies? Curr Alzheimer Res (2016) 0.75
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18
Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med (2007) 4.11
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke (2006) 3.27
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2009) 2.76
A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord (2006) 2.72
Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry (2007) 2.38
Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord (2006) 2.07
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain (2004) 2.06
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Mov Disord (2013) 1.98
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry (2002) 1.96
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry (2002) 1.88
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am J Psychiatry (2004) 1.82
Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry (2011) 1.79
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. J Clin Psychiatry (2004) 1.74
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. Br J Psychiatry (2002) 1.67
Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63
Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? Mov Disord (2013) 1.61
The dex/CRH test--is it better than the DST? Psychoneuroendocrinology (2006) 1.59
Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study. Br J Psychiatry (2011) 1.58
Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry (2012) 1.57
Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry (2005) 1.54
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology (2013) 1.53
Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects. Neuroimage (2004) 1.53
The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better. J Psychopharmacol (2003) 1.45
Depression and vascular disease: what is the relationship? J Affect Disord (2004) 1.43
Increase in interleukin-1beta in late-life depression. Am J Psychiatry (2005) 1.40
Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry (2004) 1.39
Hippocampal volume change in depression: late- and early-onset illness compared. Br J Psychiatry (2004) 1.37
Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care (2006) 1.31
Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (2010) 1.31
Neuropathological correlates of late-life depression in older people. Br J Psychiatry (2011) 1.29
The spectrum of nonmotor symptoms in early Parkinson disease. Neurology (2013) 1.29
Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. Brain atrophy, WMH change and blood pressure. J Neurol (2007) 1.28
Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review. BMC Neurol (2006) 1.27
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology (2004) 1.24
Subjective memory complaints, white-matter lesions, depressive symptoms, and cognition in elderly patients. Am J Geriatr Psychiatry (2005) 1.21
Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain (2012) 1.21
A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19
PET imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry (2010) 1.16
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain (2005) 1.16
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain (2011) 1.13
A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disord (2004) 1.12
Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension (2013) 1.12
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry (2005) 1.11
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging (2006) 1.11
More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry (2006) 1.10
Depression and cognition in older adults. Curr Opin Psychiatry (2008) 1.10
A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry (2004) 1.08
Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry (2002) 1.08
Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry (2006) 1.05
Characteristics of visual hallucinations in Parkinson disease dementia and dementia with lewy bodies. Am J Geriatr Psychiatry (2006) 1.05
Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke (2008) 1.05
Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease. Neuroimage (2007) 1.04
Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry (2003) 1.02
Depressive symptoms and cognitive decline in community-dwelling older adults. J Am Geriatr Soc (2010) 1.02
Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci (2002) 1.01
Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord (2003) 1.01
Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study. Br J Psychiatry (2012) 1.00
Functional connectivity in late-life depression using resting-state functional magnetic resonance imaging. Am J Geriatr Psychiatry (2010) 1.00
Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke (2011) 0.99
Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry (2006) 0.99
Validation of a fully automated hippocampal segmentation method on patients with dementia. Hum Brain Mapp (2008) 0.99
Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Psychiatry Res (2007) 0.98
MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 0.97
Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord (2005) 0.97
A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord (2003) 0.97
A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry (2012) 0.97
Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology (2012) 0.97
Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry (2012) 0.97
Cortical thickness and VBM-DARTEL in late-life depression. J Affect Disord (2011) 0.97
Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr (2011) 0.96
The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord (2009) 0.95
Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr Res (2007) 0.95
Dementia with Lewy bodies. Semin Clin Neuropsychiatry (2003) 0.94
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS study. J Neurol (2012) 0.94
Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease. Brain (2011) 0.93
A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr (2008) 0.93
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord (2006) 0.93
Impaired working memory monitoring in euthymic bipolar patients. Bipolar Disord (2007) 0.93
The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage (2004) 0.92
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2007) 0.91
Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging (2011) 0.91
High resolution imaging of the medial temporal lobe in Alzheimer's disease and dementia with Lewy bodies. J Alzheimers Dis (2010) 0.91
White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry (2010) 0.91
White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry (2010) 0.90
Emission tomography in dementia. Nucl Med Commun (2005) 0.90
Revised criteria for Alzheimer's disease: what are the lessons for clinicians? Lancet Neurol (2011) 0.89